Search Within

Isabelle C Riviere

  1. "Jolanta Stefanski"
  2. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (8)
Groups
  1. Center for Hematologic Malignancies (28)
  2. Department of Medicine (28)
  3. GSK Faculty (28)
  4. Hematologic Malignancies Research (28)
  5. Hematologic Malignancies, Division of (28)
  6. Molecular Pharmacology and Chemistry Program Faculty (28)

More Groups

People
  1. Jolanta Stefanski (28)
  2. Michel Sadelain (28)
  3. Xiuyan Wang (20)
  4. Renier Brentjens (17)
  5. Oriana Borquez-Ojeda (16)
  6. Shirley Bartido (16)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (3)

More Years

Publications
  1. Blood (7)
  2. Molecular Therapy (7)
  3. Cancer Research (4)
  4. Journal of Clinical Oncology (3)
  5. Gene Therapy (2)
  6. Human Gene Therapy (2)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. American Society of Hematology (7)
  3. American Association for Cancer Research (4)
  4. American Society of Clinical Oncology (3)
  5. American Association for the Advancement of Science (2)
  6. Mary Ann Liebert, Inc (2)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FT819 path to IND: First-of-kind off-the-shelf CAR19 T-cell for B cell malignancies
    Meeting Abstract

    Mandal, M.; Clarke, R.; van der Stegen, S.; Chang, C. W.; Lai, Y. S.; Witty, A.; Husain, M.; Wu, C. J.; Yang, B. H.; Dufaud, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial
    Meeting Abstract

    Abujarour, R.; Lai, Y. S.; Pribadi, M.; Lee, T.; Robinson, M.; Ruller, C.; Van der Stegen, S.; Wang, X.; Stefanski, J.; Zhen, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CAR-T cell manufacturing with CliniMACS Prodigy
    Meeting Abstract

    Wang, X.; Stefanski, J.; Chaudhari, J.; Hall, M.; Thummar, K.; Zhao, Z.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • Selection and purification of CD34+ cells from cryopreserved cord blood units using CliniMACS Plus and CliniMACS Prodigy
    Meeting Abstract

    Wang, X. Y.; Stefanski, J.; Hack, A.; He, Q.; Boyle, R.; Barker, J.; Scandura, J.; Rafii, S.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2017)

    Fulltext@MSK | Save
  • Evaluation of Miltenyi ExpAct and TransAct CD3/28 beads for CAR-T cell manufacturing
    Meeting Abstract

    Wang, X.; Qu, J.; Stefanski, J.; Borquez-Ojeda, O.; Hack, A.; He, Q.; Wasielewska, T.; Du, F.; Sadelain, M.; Rivière, I.
    Molecular Therapy (2016)

    Fulltext@MSK | Save
  • Comparison of CTS™ Dynabeads® CD3/CD28, Miltenyi TransAct CD3/28 and ExpAct Beads for large-scale CAR T cell manufacturing
    Meeting Abstract

    Wang, X.; Stefanski, J.; Borquez-Ojeda, O.; Qu, J.; Hack, A.; He, Q.; Wasielewska, T.; Du, F.; Sadelain, M.; Riviere, I.
    Human Gene Therapy (2015)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Sadelain, M.; Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; Stefanski, J.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
    Blood (2013)

    Fulltext@MSK | Save